Related Experiment Videos
Relative potencies for barbiturate binding to the Torpedo acetylcholine receptor
B A Dodson1, R R Urh, K W Miller
1Department of Anaesthesia, Massachusetts General Hospital, Harvard Medical School, Boston 02114.
British Journal of Pharmacology
|November 1, 1990
Summary
Researchers identified two distinct classes of barbiturates affecting acetylcholine receptor binding sites. Ten barbiturates strongly inhibited binding, while four showed minimal effects, revealing structural requirements for allosteric interactions.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- The acetylcholine receptor (AChR) is a crucial neurotransmitter receptor in the nervous system.
- Barbiturates are known to modulate neuronal activity, but their specific binding sites on receptors require detailed characterization.
Purpose of the Study:
- To characterize the structural requirements of the allosteric barbiturate binding site on acetylcholine receptor-rich membranes.
- To investigate the differential binding affinities and effects of various barbiturates on [14C]-amobarbitone displacement.
Main Methods:
- Utilized acetylcholine receptor-rich membranes from Torpedo electroplaques.
- Quantified the ability of fourteen different barbiturates to displace [14C]-amobarbitone binding.
Main Results:
- Barbiturates were categorized into two classes: ten with strong inhibition (Class I) and four with minimal effects (Class II) on [14C]-amobarbitone binding.
- Class I barbiturates exhibited apparent inhibition constants (KI) ranging from 13 µM to 2.8 mM, with a defined rank order of potency.
- Class II barbiturates, all N-methylated, showed minimal or no significant inhibition, indicating distinct structural or chemical properties.
Conclusions:
- The study delineates specific structural features dictating barbiturate interaction with the allosteric binding site on acetylcholine receptors.
- The findings provide a basis for understanding structure-activity relationships of barbiturates at the nicotinic acetylcholine receptor.
- N-methylation appears to be a key feature distinguishing barbiturates with low affinity for this specific binding site.